Epilepsy patients treated with antiepileptic drug therapy exhibit compromised ocular perfusion characteristics

Epilepsia

Volumn 43, Issue 11, 2002, Pages 1346-1350

  Roff Hilton, Emma J ^a   Hosking, Sarah L ^a   Betts, Tim ^b  

^a ASTON UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Ocular blood flow; Retinal perfusion; Scanning laser Doppler flowmetry

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; GABAPENTIN; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID; VIGABATRIN;

ADULT; ARTICLE; BRAIN BLOOD FLOW; CAPILLARY FLOW; CLINICAL ARTICLE; EPILEPSY; FEMALE; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; HEMODYNAMICS; HUMAN; LASER DOPPLER FLOWMETRY; MALE; PRIORITY JOURNAL; RETINA BLOOD FLOW; VISION;

ADULT; ANTICONVULSANTS; BLOOD FLOW VELOCITY; BLOOD VOLUME; CAPILLARIES; COHORT STUDIES; EPILEPSY; EYE; FEMALE; HUMANS; LASER-DOPPLER FLOWMETRY; MALE; REFERENCE VALUES; REGIONAL BLOOD FLOW; RETINAL VESSELS;

EID: 0036852752     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.2002.44901.x     Document Type: Article

References (36)

1. Kahane P, Mauguiere F. Ictal cerebral blood flow (CBF) changes studied by positron emission tomography (PET) and simultaneous stereoelectroencephalographic recordings (SEEG). Rev Neurol 1999;155:472-6.
2. Hill RA, Chiappa KH, HuangHellinger F, et al. Hemodynamic and metabolic aspects of photosensitive epilepsy revealed by functional magnetic resonance imaging and magnetic resonance spectroscopy. Epilepsia 1999;40:912-20.
3. Rabinowicz AL, Salas E, Besberra F, et al. Changes in regional cerebral blood flow beyond the temporal lobe in unilateral temporl lobe epilepsy. Epilepsia 1997;38:1011-4.
4. DeSimone R, Silvestrini R, Marciani MG, et al. Changes in cerebral blood flow velocities during childhood absence seizures. Pediatr Neurol 1998;18:132-5.
5. Theodore WH. Antiepileptic drugs and cerebral glucose metabolism. Epilepsia 1988;29(suppl 2):S48-55.
6. Matsuda H, Fukuchi T, Onuma T, et al. Interictal cerebral and cerebellar blood flow in temporal lobe epilepsy as measured by a non-invasive technique using Tc-99m HMPAO. Clin Nucl Med 1996;21:867-72.
7. Spanaki MV, Siegel H, Kopylev L, et al. The effect of vigabatrin (γ-vinyl GABA) on cerebral blood flow and metabolism. Neurology 1999;53:1518-22.
8. Harris A, Arend O, Kopecky K, et al. Physiological perturbation of ocular and cerebral blood flow as measured by scanning laser ophthalmoscopy and color Doppler imaging. Surv Ophthalmol 1994;38:S81-6.
9. 2: Acute effects on cerebral and retrobulbar hemodynamics. J Glaucoma 1996:5:39-45.
10. 2 responsiveness of cerebral and ocular circulation in humans. Am J Physiol 1997;273:R2005-12.
11. Kiss B, Dallinger S, Findl O, et al. Acetazolamide-induced cerebral and ocular vasodilation in humans is independent of nitric oxide. Am Physiol J 1999;276:R1661-7.
12. Ludwig BL, Marsan CA. Clinical ictal patterns in epileptic patients with occipital electroencephalographic foci. Neurology 1975;25 463-71.
13. Bayer A, Thiel HJ, Zrenner E, et al. Colour vision deficiencies and enhanced sensitivity to glare in epileptic patients treated with carbamazepine and phenytoin: Ocular side-effects of anti-epileptic drugs. Nervenarzt 1995;66:89-96.
14. Steinhoff BJ, Freudenthaler N, Paulus W. The influence of established and new antiepileptic drugs on visual perception, II: A controlled study in patients with epilepsy under long-term antiepileptic medication. Epilepsy Res 1997;29:49-58.
15. Eke T, Talbot JF, Lawden MC. Severe persistent visual field constriction associated with vigabatrin. Br Med J 1997;314:180-1.
16. Krauss GL, Johnson MA, Miller NR. Vigabatrin-associated retinal cone system dysfunction. Neurology 1998;50:614-8.
17. Krauss G, Miller NR. Vigabatrin: An effective antiepilepsy drug: Balancing the risk of visual dysfunction. Ann Pharmacother 1999;33:1367-8.
18. Nousiainen I, Kalviainen R, Mantyjarvi M. Color vision in epilepsy patients treated with vigabatrin or carbamazepine monotherapy. Ophthalmology 2000;107:884-8.
19. Nousiainen I, Kalviainen R, Mantyjarvi M. Contrast and glare sensitivity in epilepsy patients treated with vigabatrin or carbamazepine monotherapy compared with healthy volunteers. Br J Ophthalmol 2000;84:622-5.
20. Manuchehri K, Goodman S, Siviter L, et al. A controlled study of vigabatrin and visual abnormalities. Br J Ophthalmol 2000;84: 499-505.
21. Hilton EJR, Cubbidge RP, Hosking SL, Betts T, Comaish IF. Patients treated with vigabatrin exhibit central visual function loss. Epilepsia 2002;43:1351-9.
22. Claridge KG, Smith SE. Diurnal variation in pulsatile ocular blood flow in normal and glaucomatous eyes. Surv Ophthalmol 1994;38: S198-205.
23. Michelson G, Schmauss B. Two dimensional mapping of the perfusion of the retina and optic nerve head. Br J Ophthalmol 1995;79:1126-32.
24. Michelson G, Schmauss B, Langhans MJ, et al. Principle, validity, and reliability of scanning laser Doppler flowmetry. J Glaucoma 1996;5:99-105.
25. Hosking SL, Embleton SJ, Cunliffe IA. Application of a local search strategy demonstrates preferential loss of high-velocity blood flow in the neuroretinal rim of glaucoma patients, using scanning laser Doppler flowmetry. Br J Ophthalmol 2001;85:1298-1302.
26. Hosking SL, Embleton SJ, Kagemann L, Chabra A, Jonescu-Cuypers C, Harris A. Detector sensitivity influences blood flow sampling in scanning Laser Doppler flowmetry. Graefes Arch Clin Exp Ophthalmol 2001;239:407-10.
27. Galassi F, Nuzzaci G, Sodi A, et al. Possible correlations of ocular blood-flow parameters with intraocular-pressure and visual-field alterations in glaucoma: A study by means of color Doppler imaging. Ophthalmologica 1994;208:304-8.
28. Nicolela MT, Drance SM, Rankin SJA, et al. Color Doppler imaging in patients with asymmetric glaucoma and unilateral visual field loss. Am J Ophthalmol 1996;121:502-10.
29. Michelson G, Langhans M, Dichtl A, et al. Impaired perfusion of the juxtapapillary retina and the neuroretinal rim area precede visual field loss in primary open angle glaucoma (POAG). Invest Ophthalmol Vis Sci 1996;37:2101-1.
30. Quigley HA, Nickells RW, Kerrigan LA, et al. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci 1995;36:774-86.
31. Levin LA. Direct and indirect approaches to neuroprotective therapy of glaucomatous optic neuropathy. Surv Ophthalmol 1999;43:S98-101.
32. Dreyer EB, Grosskreutz CL. Excitatory mechanisms in retinal ganglion cell death in primary open angle glaucoma (POAG). Clin Neurosci 1997;4:270-3.
33. Lloyd GK, Gillenwater G. Epilepsy and antiepileptic drugs. In: Munson PL, ed. Principles of Pharmacology. New York: Chapman & Hall, 1995:363-98.
34. Michelson G, Welzenbach J, Pal I, et al. Automatic full field analysis of perfusion images gained by scanning laser Doppler flowmetry. Br J Ophthalmol 1998;82:1294-300.
35. Chauhan BC, Smith FM. Confocal scanning laser Doppler flowmetry: Experiments in a model flow system. J Glaucoma 1997;6: 237-45.
36. Bohdanecka Z, Orgül S, Prünte C, et al. Influence of acquisition parameters on hemodynamic measurements with the Heidelberg retina flowmeter at the optic disc. J Glaucoma 1998;7:151-7.